This blog is related to the various litigations related to patents w.r.t pharma industry.
Sunday, April 12, 2009
New Keppra XR Dosage Strength Offers Simplified Treatment Option for People Living With Partial-Onset Seizures
Keppra XR (levetiracetam) extended-release tablets are now available in a new dosage strength--750 mg--enabling doctors to simplify patients' treatment plans by decreasing the number of tablets they take each day.
No comments:
Post a Comment